NO20090333L - Fremgangsmater og preparater rettet mot hepsin - Google Patents

Fremgangsmater og preparater rettet mot hepsin

Info

Publication number
NO20090333L
NO20090333L NO20090333A NO20090333A NO20090333L NO 20090333 L NO20090333 L NO 20090333L NO 20090333 A NO20090333 A NO 20090333A NO 20090333 A NO20090333 A NO 20090333A NO 20090333 L NO20090333 L NO 20090333L
Authority
NO
Norway
Prior art keywords
methods
directed against
preparations directed
against hepsin
hepsin
Prior art date
Application number
NO20090333A
Other languages
English (en)
Norwegian (no)
Inventor
Daniel K Kirchhofer
Rajesh Vij
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of NO20090333L publication Critical patent/NO20090333L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pregnancy & Childbirth (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20090333A 2006-06-22 2009-01-21 Fremgangsmater og preparater rettet mot hepsin NO20090333L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80558906P 2006-06-22 2006-06-22
PCT/US2007/071688 WO2007149932A2 (en) 2006-06-22 2007-06-20 Methods and compositions for targeting hepsin

Publications (1)

Publication Number Publication Date
NO20090333L true NO20090333L (no) 2009-03-23

Family

ID=38754528

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090333A NO20090333L (no) 2006-06-22 2009-01-21 Fremgangsmater og preparater rettet mot hepsin

Country Status (16)

Country Link
US (2) US8124352B2 (pt)
EP (1) EP2044124A2 (pt)
JP (1) JP2009540835A (pt)
KR (1) KR101410195B1 (pt)
CN (1) CN101490088B (pt)
AU (1) AU2007260950B2 (pt)
BR (1) BRPI0712273A8 (pt)
CA (1) CA2656168A1 (pt)
IL (1) IL195561A (pt)
MX (1) MX2008015882A (pt)
MY (1) MY150643A (pt)
NO (1) NO20090333L (pt)
NZ (1) NZ573178A (pt)
RU (1) RU2009101813A (pt)
WO (1) WO2007149932A2 (pt)
ZA (1) ZA200810225B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7947436B2 (en) 2004-12-13 2011-05-24 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in the process of bone remodeling
MX2008015882A (es) 2006-06-22 2009-01-12 Genentech Inc Metodos y composiciones para hacer blanco en hepsina.
EP2491059B1 (en) * 2009-10-22 2015-02-25 F.Hoffmann-La Roche Ag Anti-hepsin antibodies and methods using same
BR112012009409A2 (pt) * 2009-10-22 2017-02-21 Genentech Inc método de identificação de uma substância inibidora, molécula antagonista, ácido nucleico isolado, vetor, célula hospedeira, método para fabricar a molécula, composição, artigo de fabricação, método de inibição de uma atividade biológica, método de tratamento de uma condição patológica, método para detectar msp em uma amostra e método para detectar hepsina em uma amostra
JP5797210B2 (ja) * 2010-03-02 2015-10-21 シアトル ジェネティックス， インコーポレイテッド 抗体をスクリーニングするための方法
WO2011161189A1 (en) 2010-06-24 2011-12-29 F. Hoffmann-La Roche Ag Anti-hepsin antibodies and methods of use
DK3415531T3 (da) * 2011-05-27 2023-09-18 Glaxo Group Ltd Bcma (cd269/tnfrsf17)-bindende proteiner
UA112434C2 (uk) 2011-05-27 2016-09-12 Ґлаксо Ґруп Лімітед Антигензв'язувальний білок, який специфічно зв'язується з всма
WO2017162659A1 (en) 2016-03-24 2017-09-28 Bayer Pharma Aktiengesellschaft Intracellular hepsin as therapeutic target for the treatment of cancer with centrosome amplification

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268165B1 (en) 1997-03-19 2001-07-31 The Board Of Trustees Of The University Of Arkansas Methods for the early diagnosis of ovarian cancer
US7282198B2 (en) 1997-03-19 2007-10-16 The University Of Arkansas For Medical Sciences Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme
US5981830A (en) * 1997-05-30 1999-11-09 Schering Aktiengesellschaft Knockout mice and their progeny with a disrupted hepsin gene
ATE496123T1 (de) 2000-02-03 2011-02-15 Dendreon Corp Nukleinsäuren, welche für tramsmembran serin proteasen kodieren, die kodierten proteine und darauf basierende methoden
US6423543B1 (en) * 2000-12-20 2002-07-23 Isis Pharmaceuticals, Inc. Antisense modulation of hepsin expression
US20030013097A1 (en) * 2001-01-23 2003-01-16 Welsh John Barnard Genes overexpressed in prostate disorders as diagnostic and therapeutic targets
AU2002240336A1 (en) * 2001-02-14 2002-08-28 Tularik Inc. Methods for the diagnosis and treatment of tumors employing the hepsin gene
US6482630B2 (en) * 2001-03-29 2002-11-19 Applera Corporation Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
US7229774B2 (en) * 2001-08-02 2007-06-12 Regents Of The University Of Michigan Expression profile of prostate cancer
WO2003016484A2 (en) 2001-08-17 2003-02-27 Affymetrix, Inc. Gleason grade 4/5 prostate cancer genes
AU2003225540A1 (en) * 2002-01-31 2003-09-02 Irm, Llc Hepsin substrates and prodrugs
US20040001801A1 (en) * 2002-05-23 2004-01-01 Corvas International, Inc. Conjugates activated by cell surface proteases and therapeutic uses thereof
JP3775346B2 (ja) * 2002-05-29 2006-05-17 株式会社日立製作所 テレビ電話システムおよびその端末装置
WO2004009803A2 (en) 2002-07-23 2004-01-29 Bayer Healthcare Ag Regulation of human hepsin
US6977170B2 (en) 2002-09-06 2005-12-20 Applera Corporation Isolated human hepsin/46 proteins, nucleic acid molecules encoding human hepsin/46 proteins, and uses thereof
EP1558731A4 (en) * 2002-10-04 2007-01-10 Schering Ag MODIFIED HEPSINE MOLECULES COMPRISING A SUBSTITUTION ACTIVATION SEQUENCE AND USES THEREOF
JP5226308B2 (ja) 2004-07-26 2013-07-03 ジェネンテック， インコーポレイテッド 肝細胞増殖因子活性化を制御するための方法及び組成物
MX2008015882A (es) 2006-06-22 2009-01-12 Genentech Inc Metodos y composiciones para hacer blanco en hepsina.
NZ596729A (en) 2006-06-22 2012-11-30 Genentech Inc Methods for identifying a candidate inhibitor substance that inhibits hepsin activation of pro-urokinase type plasminogen activator
EP2491059B1 (en) * 2009-10-22 2015-02-25 F.Hoffmann-La Roche Ag Anti-hepsin antibodies and methods using same

Also Published As

Publication number Publication date
US20100021474A1 (en) 2010-01-28
US8383123B2 (en) 2013-02-26
IL195561A0 (en) 2011-08-01
WO2007149932A2 (en) 2007-12-27
AU2007260950A8 (en) 2009-01-22
ZA200810225B (en) 2010-03-31
AU2007260950A1 (en) 2007-12-27
US20120141374A1 (en) 2012-06-07
EP2044124A2 (en) 2009-04-08
WO2007149932A3 (en) 2008-05-02
MX2008015882A (es) 2009-01-12
BRPI0712273A2 (pt) 2012-03-06
MY150643A (en) 2014-02-14
BRPI0712273A8 (pt) 2019-01-22
CN101490088B (zh) 2015-04-08
JP2009540835A (ja) 2009-11-26
KR20090029276A (ko) 2009-03-20
AU2007260950B2 (en) 2011-09-15
CA2656168A1 (en) 2007-12-27
IL195561A (en) 2013-04-30
KR101410195B1 (ko) 2014-06-19
US8124352B2 (en) 2012-02-28
RU2009101813A (ru) 2010-07-27
CN101490088A (zh) 2009-07-22
NZ573178A (en) 2012-02-24

Similar Documents

Publication Publication Date Title
NO20083127L (no) Fremgangsmater og preparater for malretting av polyubiquitin
NO20084356L (no) Anti TAT226-antistoffer og immunokonjugater
NO20090333L (no) Fremgangsmater og preparater rettet mot hepsin
NO20092052L (no) Antistoffer og immunkonjugater, og anvendelser derav
NO20085396L (no) Antistoffer og immunkonjugater, og anvendelser derav
CY1118343T1 (el) Αντισωματα συνδεσης twεακ
SG170091A1 (en) Anti-5t4 antibodies and uses thereof
NO20083397L (no) Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse
DK3656793T3 (da) Monoklonale antistoffer mod claudin-18 til cancerbehandling
NL1027975A1 (nl) Antilichamen tegen MAdCAM.
CY1110337T1 (el) Παρασκευη πρεγκαμπαλινης και σχετικων ενωσεων
DK2176296T3 (da) Anti-CD79B-antistoffer og immunkonjugater og anvendelsesfremgangsmåder.
WO2007008943A3 (en) Optimized anti-ep-cam antibodies
ATE474617T1 (de) Medizinproduktsysteme
ZA200804868B (en) Anti-OX40L antibodies and methods using same
NO20083593L (no) Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse
DK1907854T3 (da) Monoklonale antistoffer, hybridomcellelinjer, fremgangsmåder og kits til detektion af phytase
DK1768691T3 (da) Aequorinholdige præparater og fremgangsmåder til anvendelse af samme
NO20083609L (no) Fremgangsmater og sammensetninger for malrettet-RELT
NO20042767D0 (no) Sammenforingssystem, enkeltelementer og fremgangsmate for bruk av dette
NO20080409L (no) Fremgangsmater og preparater til malsoking av IFNAR2
WO2006031831A3 (en) Methods for the detection of ovarian cancer
ES1058780Y (es) Brida de union autoblocante.
CR20140126A (es) Anticuerpos anti-tat226 e inmunoconjugados
TR200602530U (tr) Kılavuz ipe dizili boncuk

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application